promo
BMI - Management
IA  CEO, Dr. Ingrid Alfheim has held leading positions in R&D Management and  Business Development in the diagnostics industry. She has been instrumental in commercializing biomedical research through her active participation in various company boards and governmental committees.    
HD 

Vice President, New Projects, Harald Dugstad has held management positions and worked with IP strategy in international pharmaceutical industry, and has also several years of experience in business development within new biomedical innovations.

  TG Vice President, Cardiovascular, Dr. Trygve Gulbrandsen has wide-ranging international experience in project management, technology transfer and business development in the pharmaceutical industry.
 HMDK Vice Presiedent, Oncology, Hanne Mette D. Kristensen has a strong track record in the commercialization of research and early phase company development. She holds an M.Sc. in biochemistry from the University of Oslo and an MBA in Technology Management  (MTM) from NTNU, NHH and MIT, Sloan School of Management.  OHAB Vice President, Immunology, Dr. Ole Henrik Brekke has a PhD degree in Molecular Cell Biology from the University of Oslo. He has been R&D director in Affitech AS and in Dynal-Invitrogen. After being with Birkeland Innovation AS Ole Henrik joined BMI in August 2008.